Monoclonal Antibodies for Protozoan Infections: A Future Reality or a Utopic Idea? [PDF]
Following the SARS-CoV-2 pandemic, several clinical trials have been approved for the investigation of the possible use of mAbs, supporting the potential of this technology as a therapeutic approach for infectious diseases. The first monoclonal antibody (
Silvia Stefania Longoni +4 more
doaj +3 more sources
Seroprevalence rates of antibodies againstLeishmania infantum and other protozoan and rickettsial parasites in dogs [PDF]
Canine visceral leishmaniasis (CVL) is caused by the protozoan Leishmania infantum, which infects dogs and humans in many regions of Brazil. The present study involved an indirect fluorescent antibody test (IFAT) to analyze L.
Silvana de Cássia Paulan +7 more
doaj +4 more sources
Occurrence and Risk Factors of Toxoplasma gondii Infection in Tigers (Panthera tigris) in Thailand: Influence of Age and Sex [PDF]
Background Toxoplasma gondii is a zoonotic protozoan parasite of significant concern in both public and animal health. Objectives This study investigated the occurrence of T.
Phirom Prompiram +4 more
doaj +2 more sources
B-Cell Response during Protozoan Parasite Infections [PDF]
In this review, we discuss how protozoan parasites alter immature and mature B cell compartment. B1 and marginal zone (MZ) B cells, considered innate like B cells, are activated during protozoan parasite infections, and they generate short lived plasma ...
María C. Amezcua Vesely +4 more
doaj +2 more sources
Serosurvey of Toxoplasmosis Among Drug Users in Fars Province, Southern Iran: A Cross-Sectional Study. [PDF]
ABSTRACT Background and Aims Toxoplasma gondii is a widespread zoonotic protozoan that poses significant health risks, particularly to immunocompromised individuals. Although generally asymptomatic, toxoplasmosis can lead to severe neurological complications and behavioral disorders.
Cheraghi MR +10 more
europepmc +2 more sources
Effect of biannual azithromycin distribution on antibody responses to malaria, bacterial, and protozoan pathogens in Niger [PDF]
Abstract The MORDOR trial in Niger, Malawi, and Tanzania found that biannual mass distribution of azithromycin to children younger than 5 years led to a 13.5% reduction in all-cause mortality (NCT02048007). To help elucidate the mechanism for mortality reduction, we report IgG responses to 11 malaria, bacterial ...
Ahmed M. Arzika +15 more
openaire +5 more sources
Development of antibodies for life-detection experiment in extreme environments; implications for astrobiology [PDF]
The Life Marker Chip (LMC) instrument is an antibody assay-based system which will attempt to detect molecular signatures of Life in the Martian subsurface as part of the payload on board the European Space Agency (ESA) ExoMars mission rover, currently
Derveni, Maria Elisavet
core +7 more sources
Use of Phage Antibodies to Distinguish Closely Related Species of Protozoan Parasites [PDF]
Acanthamoeba are typically identified in the laboratory using culture and microscopic observation. In this paper we describe the isolation and specificity of antibody fragments that can be used for the identification of Acanthamoeba. A phage library expressing a large repertoire (approx.
Timothy Paget +4 more
openaire +2 more sources
Specificity of SARS-CoV-2 antibody-detection assays against S and N protein among pre-COVID-19 sera from patients with protozoan and helminth parasitic infections [PDF]
ABSTRACT Background We aimed to assess the specificity of SARS-CoV-2 antibody detection assays among people with known tissue-borne parasitic infections. Methods We tested three SARS-CoV-2 antibody-detection assays (cPass SARS-CoV ...
Cedric P. Yansouni +12 more
openaire +2 more sources
Adaptation of CUT&RUN for use in African trypanosomes.
This Cleavage Under Targets and Release Using Nuclease (CUT&RUN) protocol produces genomic occupancy data for a protein of interest in the protozoan parasite Trypanosoma brucei. The data produced is analyzed in a similar way as that produced by ChIP-seq.
Geneva Miller +4 more
doaj +1 more source

